PipelineRx gets funding boost to accelerate growth

PipelineRx said Tuesday it has received a $9.1 million round of funding led by Mitsui & Co., Inc., and also involving McKesson Ventures and AMN Healthcare.

PipelineRX will use the investment to strengthen its technology offerings as integrated delivery networks (IDNs) and hospitals look to grow workflow models leading to better patient care, while assessing areas of growth.

“PipelineRx’s innovative telepharmacy solution has been gaining momentum with hospital clients helping them manage their pharmacy operations better,”  Mitsui USA General Manager of Health Care Business Junjiro Sato said. “We’re excited to forge a new partnership with PipelineRx as they continue to penetrate this market as a leading provider. PipelineRx has demonstrated clinical and fiscal value in the U.S., and we look forward to exploring additional markets together.”

The investment allows PipelineRx to develop new technology offerings while bolstering existing platforms to further support larger IDNs.

“Now more than ever, IDNs need tools that drive greater efficiencies and ensure pharmacists are appropriately focused on clinical performance and outcomes,” McKesson Ventures Senior Vice President and Managing Director Tom Rodgers said. “PipelineRx’s solution provides a platform for IDNs to accomplish both goals by enabling them to leverage in-house pharmacists across their network or supplement with the help of PipelineRx’s outsourced services.”